- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 127,730 | 02.07.24 21:31:39 | -0,170 | -0,13% | 127,720 | 127,730 | 128,210 | 127,900 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 85,350 | 02.07.24 21:31:28 | +0,500 | +0,59% | 85,240 | 85,450 | 83,760 | 84,850 |
